1. Removal of the 2.2.2 Cryptand (Kryptofix 2.2.2™) from 18FDG by cation exchange;Alexoff;Appl. Radiat. Isot. (Int. J. Radiat. Appl. Instrum. Part A),1991
2. Thin layer chromatographic detection of Kryptofix 2.2.2 in the routine synthesis of [18F]2-fluoro-2-deoxy-d-glucose;Chaly;Nucl. Med. Biol. (Int. J. Radiat. Appl. Instrum. Part. B),1989
3. Chen, J., Linder, K.E., Marinelli, E.R., Metcalfe, E., Nunn, A., Swenson, R.E., Tweedle, M., 2005. Stable radiopharmaceutical compositions and methods for their preparations. PCT Int. Appl. WO2004US23930, 117pp.
4. Recommendation for a practical production of [2-18F]fluoro-2-deoxy-d-glucose;Coenen;Appl. Radiat. Isot.,1987
5. Final report on the safety assessment of l-ascorbic acid, calcium ascorbate, magnesium ascorbate, magnesium ascorbyl phosphate, sodium ascorbate, and sodium ascorbyl phosphate as used in cosmetics;Elmore;Int. J. Toxicol.,2005